1Niessen FB,Spauwen PH,Schalkwijk J. On the nature of hypertrophic scar s and keloids:a review[J].{H}Plastic and Reconstructive Surgery,1999,(5):1435-1458.
2Leventhal D,Furr M,Reiter D. Treatment of keloids and hypertrophic scars:a meta analysis and review of the literature[J].{H}Archives of Facial Plastic Surgery,2006,(6):362-368.
3Slemp AE,Kirschner RE. Keloids and scars:a review of keloids and scars,their pathogenesis,risk factors,and management[J].{H}Current Opinion in Pediatrics,2006,(4):396-402.
4Brown JJ,Bayat A. Genetic susceptibility to raised dermal scarring[J].{H}British Journal of Dermatology,2009,(1):8-18.
5Wynn TA. Fibrotic disease and the TH1/TH2 paradigm[J].{H}Nature reviews Immunology,2004,(8):583-594.
6Tredget EE,Nedelec B,Scott PG. Hypertrophic scars,keloids,and contractures:the cellular and molecular basis for therapy[J].{H}Surgical Clinics Of North America,1997,(3):701-730.
8Ladak A,Tredget EE. Pathophysiology and management of the burn scar[J].{H}Clinics in Plastic Surgery,2009,(4):661-674.
9Gerd GG,Hans CK,Tatiana Pavicic. Hypotrophic scarring and keloids:pathomechanisms and current emerging treatment strategies[J].{H}Molecular Medicine,2011,(1-2):113-125.
10Bock O,Yu H,Zitron S. Studies of transforming growth factors beta 1-3 and their receptors Ⅰ and Ⅱ in fibroblast of keloids and hypertrophic scars[J].{H}Acta Dermato-Venereologica,2005,(3):216-220.
8Mair M, Blaas L, Osterreicher CH, et al. JAK-STAT signaling in he-parle fibrosis[J]. Front Biosci(Landmark Ed), 2011 ,(16) :2794-2811.
9Vera J, Rateitschak K, Lange F, et al. Systems biology of JAK- STAT signaling in human malignancies[J]. Prog Biophys Mol Bi- ol, 2011,106(2) :426-434.
10Matsui F, Meldrum KK. The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrot- ic renal disease[ J ]. J Surg Res, 2012,178 (1) :339-345.
